v3.26.3
Unaudited Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Collaboration revenue $ 9,289 $ 10,000 $ 23,289 $ 10,000
Operating expenses:        
Research and development 30,565 34,629 88,372 94,348
General and administrative 9,982 10,622 32,078 30,918
Total operating expenses 40,547 45,251 120,450 125,266
Loss from operations (31,258) (35,251) (97,161) (115,266)
Other income:        
Interest income 9,688 10,938 29,258 33,587
Total other income 9,688 10,938 29,258 33,587
Net loss (21,570) (24,313) (67,903) (81,679)
Other comprehensive gain (loss):        
Unrealized gain on available-for-sale securities, net (4,189) 815 (10,810) 2,399
Comprehensive loss $ (25,759) $ (23,498) $ (78,713) $ (79,280)
Net loss per common share, basic $ (0.34) $ (0.39) $ (1.08) $ (1.32)
Net loss per common share, diluted $ (0.34) $ (0.39) $ (1.08) $ (1.32)
Weighted-average shares of common stock outstanding, basic 63,089,950 62,023,685 62,899,208 61,906,789
Weighted-average shares of common stock outstanding, diluted 63,089,950 62,023,685 62,899,208 61,906,789